Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy.

RAS and BRAF inhibitors TRK inhibitors anti-HER-2 immunotherapy metastatic colorectal cancer precision medicine

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
30 Apr 2022
Historique:
received: 16 02 2022
revised: 16 04 2022
accepted: 28 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

Novel targeted therapies for metastatic colorectal cancer are needed to personalize treatments by guiding specific biomarkers selected on the genetic profile of patients.

Identifiants

pubmed: 35625772
pii: biomedicines10051035
doi: 10.3390/biomedicines10051035
pmc: PMC9138254
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Clin Oncol. 2013 Feb 20;31(6):759-65
pubmed: 23182985
Lancet Oncol. 2021 May;22(5):665-677
pubmed: 33812497
Clin Colorectal Cancer. 2021 Jun;20(2):101-112.e6
pubmed: 33223477
Lancet. 2010 Aug 28;376(9742):687-97
pubmed: 20728210
ESMO Open. 2020 Sep;5(5):e000911
pubmed: 32988996
J Natl Compr Canc Netw. 2018 Jul;16(7):874-901
pubmed: 30006429
QJM. 2016 Mar;109(3):151-8
pubmed: 26224055
Br J Cancer. 2016 Jan 12;114(1):30-6
pubmed: 26575603
Cell Death Dis. 2021 Nov 27;12(12):1109
pubmed: 34839348
J Clin Oncol. 2017 Aug 10;35(23):2624-2630
pubmed: 28486044
J Mol Diagn. 2008 Jul;10(4):301-7
pubmed: 18556776
Cancer Discov. 2011 Nov;1(6):508-23
pubmed: 22586653
Br J Cancer. 2009 Jan 27;100(2):266-73
pubmed: 19165197
J Clin Oncol. 2009 Apr 10;27(11):1822-8
pubmed: 19273701
Target Oncol. 2018 Oct;13(5):545-556
pubmed: 30276762
Clin Cancer Res. 2018 Mar 1;24(5):1082-1089
pubmed: 29208673
Clin Cancer Res. 2019 Dec 1;25(23):6899-6908
pubmed: 31263029
J Clin Oncol. 2013 Oct 10;31(29):3664-72
pubmed: 24019539
Nat Rev Clin Oncol. 2020 Jan;17(1):6
pubmed: 31772333
Lancet. 2019 Oct 19;394(10207):1467-1480
pubmed: 31631858
JCO Precis Oncol. 2021 May 03;5:
pubmed: 34036227
Gut. 2022 Jan;71(1):119-128
pubmed: 33436496
Crit Rev Oncol Hematol. 2019 Jul;139:53-66
pubmed: 31112882
J Clin Oncol. 2021 Feb 1;39(4):273-284
pubmed: 33503393
Oncotarget. 2016 Apr 23;7(23):34546-57
pubmed: 27120810
N Engl J Med. 2020 Dec 3;383(23):2207-2218
pubmed: 33264544
Ann Oncol. 2018 Jan 1;29(1):44-70
pubmed: 29155929
Nat Med. 2021 Nov;27(11):1899-1903
pubmed: 34764486
Int J Mol Sci. 2021 Jun 24;22(13):
pubmed: 34202896
Expert Opin Biol Ther. 2021 Oct;21(10):1315-1324
pubmed: 34085884
Br J Cancer. 2021 Jan;124(1):176-182
pubmed: 33204026
J Clin Oncol. 2015 Mar 1;33(7):692-700
pubmed: 25605843
J Natl Compr Canc Netw. 2018 Apr;16(4):359-369
pubmed: 29632055
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
N Engl J Med. 2020 Sep 24;383(13):1207-1217
pubmed: 32955176
ESMO Open. 2021 Jun;6(3):100113
pubmed: 33930659
Oncology (Williston Park). 2020 Sep 15;34(9):352-355
pubmed: 32965665
Lancet Oncol. 2020 Feb;21(2):271-282
pubmed: 31838007
Immunity. 2016 Mar 15;44(3):609-621
pubmed: 26944201
Lancet Oncol. 2016 Jun;17(6):738-746
pubmed: 27108243
Clin Adv Hematol Oncol. 2022 Feb;20(2):86-88
pubmed: 35120088
Genes Cancer. 2011 Mar;2(3):232-60
pubmed: 21779496
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Ann Oncol. 2011 Jul;22(7):1535-1546
pubmed: 21228335
Eur J Cancer. 2015 Mar;51(5):587-94
pubmed: 25673558
J Clin Oncol. 2020 Aug 20;:JCO2001225
pubmed: 32816630
J Pathol. 2004 Sep;204(1):65-74
pubmed: 15307139
Int J Mol Sci. 2013 Jan 24;14(2):2370-87
pubmed: 23348930
BMC Cancer. 2020 Jul 22;20(1):683
pubmed: 32698790
J Clin Oncol. 2015 Dec 1;33(34):4032-8
pubmed: 26460303
Lancet Oncol. 2021 Sep;22(9):1290-1300
pubmed: 34339623
Lancet Oncol. 2015 Oct;16(13):1306-15
pubmed: 26338525
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
Clin Cancer Res. 2015 Mar 15;21(6):1313-20
pubmed: 25589621
Clin Cancer Res. 2016 Dec 15;22(24):6164-6175
pubmed: 27267856
N Engl J Med. 2019 Oct 24;381(17):1632-1643
pubmed: 31566309
J Clin Oncol. 2021 Nov 20;39(33):3705-3715
pubmed: 34538072
N Engl J Med. 2016 Dec 8;375(23):2255-2262
pubmed: 27959684
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Ann Oncol. 2019 Jul 1;30(7):1134-1142
pubmed: 30918950
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
Ann Oncol. 2017 Apr 1;28(4):855-861
pubmed: 28119295
Oncotarget. 2017 Jun 27;8(26):42198-42213
pubmed: 28178681
J Clin Oncol. 2018 Mar 10;36(8):773-779
pubmed: 29355075
Oncotarget. 2016 Oct 18;7(42):69060-69074
pubmed: 27542243
Clin Colorectal Cancer. 2020 Dec;19(4):256-262.e2
pubmed: 32919890
J Clin Oncol. 2019 Feb 1;37(4):286-295
pubmed: 30376427
Mod Pathol. 2020 May;33(5):924-932
pubmed: 31792356
Ann Oncol. 2021 Aug;32(8):959-967
pubmed: 33836264
Lancet Oncol. 2019 Apr;20(4):518-530
pubmed: 30857956
J Cancer Res Clin Oncol. 2020 Aug;146(8):2077-2087
pubmed: 32561975
Front Oncol. 2021 Mar 02;11:602596
pubmed: 33738249
N Engl J Med. 2003 Jul 17;349(3):247-57
pubmed: 12867608
Cancer Cell. 2010 Aug 9;18(2):160-70
pubmed: 20708157
Oncologist. 2019 Oct;24(10):1395-1402
pubmed: 30952821
N Engl J Med. 2009 Apr 2;360(14):1408-17
pubmed: 19339720
J Clin Oncol. 2021 Feb 20;39(6):642-651
pubmed: 33356421
Clin Transl Oncol. 2022 Jun;24(6):981-996
pubmed: 35091998
Lancet Oncol. 2021 Jun;22(6):779-789
pubmed: 33961795
Cancer Cell. 2018 Jul 9;34(1):148-162.e7
pubmed: 29990497
Nat Rev Clin Oncol. 2018 Nov;15(11):709-720
pubmed: 30275515
Cell. 2022 Feb 3;185(3):563-575.e11
pubmed: 35120664
Cancer Metastasis Rev. 2020 Dec;39(4):1143-1157
pubmed: 32648137
Clin Cancer Res. 2021 May 1;27(9):2505-2514
pubmed: 33547199
Nature. 2018 Feb 8;554(7691):189-194
pubmed: 29420467
Clin Cancer Res. 2019 Dec 1;25(23):7089-7097
pubmed: 31515458
Mod Pathol. 2015 Nov;28(11):1481-91
pubmed: 26449765
J Clin Oncol. 2015 Dec 1;33(34):4023-31
pubmed: 26392102
N Engl J Med. 2020 Feb 27;382(9):877-878
pubmed: 32101678
Ann Oncol. 2016 Aug;27(8):1386-422
pubmed: 27380959
Radiol Oncol. 2019 Sep 24;53(3):265-274
pubmed: 31553708
J Clin Oncol. 2016 Jan 10;34(2):179-85
pubmed: 26438111
J Natl Cancer Inst. 2017 Dec 1;109(12):
pubmed: 29370427
N Engl J Med. 2014 Oct 23;371(17):1609-18
pubmed: 25337750
J Clin Oncol. 2023 May 10;41(14):2628-2637
pubmed: 36763936
J Clin Oncol. 2011 Apr 1;29(10):1261-70
pubmed: 21383284
Int J Cancer. 2015 Jan 1;136(1):83-90
pubmed: 24806288
Ann Oncol. 2019 Jan 1;30(1):124-131
pubmed: 30339194
Ann Oncol. 2016 Sep;27(9):1746-53
pubmed: 27358379
Lancet Oncol. 2020 Apr;21(4):497-507
pubmed: 32164906
JAMA Oncol. 2021 Dec 01;7(12):1873-1881
pubmed: 34647966
Cancers (Basel). 2020 Nov 23;12(11):
pubmed: 33238621
Cancer Res. 2017 Oct 1;77(19):5374-5383
pubmed: 28819024
Acta Pharm Sin B. 2021 Feb;11(2):355-372
pubmed: 33643817
Cancer Treat Rev. 2009 May;35(3):262-71
pubmed: 19117687
Ann Oncol. 2018 May 1;29(5):1108-1119
pubmed: 29659677
J Clin Oncol. 2017 May 1;35(13):1453-1486
pubmed: 28165299
Br J Cancer. 2015 Jun 9;112(12):1888-94
pubmed: 25989278
Cancer Discov. 2017 Jun;7(6):610-619
pubmed: 28363909
J Visc Surg. 2021 Dec;158(6):487-496
pubmed: 33975809
Lancet Oncol. 2019 Jun;20(6):849-861
pubmed: 31003911
N Engl J Med. 2013 Sep 12;369(11):1023-34
pubmed: 24024839

Auteurs

Gerardo Rosati (G)

Medical Oncology Unit, "S. Carlo" Hospital, 85100 Potenza, Italy.

Giuseppe Aprile (G)

Department of Oncology, "San Bortolo" General Hospital, Azienda ULSS8 Berica, 36100 Vicenza, Italy.

Alfredo Colombo (A)

Medical Oncology Unit, CDC Macchiarella, 90138 Palermo, Italy.

Stefano Cordio (S)

Medical Oncology Unit, "Maria Paternò Arezzo" Hospital, 97100 Ragusa, Italy.

Marianna Giampaglia (M)

Medical Oncology Unit, "S. Carlo" Hospital, 85100 Potenza, Italy.

Alessandro Cappetta (A)

Department of Oncology, "San Bortolo" General Hospital, Azienda ULSS8 Berica, 36100 Vicenza, Italy.

Concetta Maria Porretto (CM)

Medical Oncology Unit, CDC Macchiarella, 90138 Palermo, Italy.

Alfonso De Stefano (A)

Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori IRCCS-Fondazione "G. Pascale", 80121 Napoli, Italy.

Domenico Bilancia (D)

Medical Oncology Unit, "S. Carlo" Hospital, 85100 Potenza, Italy.

Antonio Avallone (A)

Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori IRCCS-Fondazione "G. Pascale", 80121 Napoli, Italy.

Classifications MeSH